Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

SOLENO THERAPEUT. DL-001

6XC
Current price
50.55 EUR -2.3 EUR (-4.35%)
Last closed 53.4 EUR
Company
ISIN US8342033094
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 2 305 951 272 EUR
Yield for 12 month +137.32 %
1Y
3Y
5Y
10Y
15Y
6XC
21.11.2021 - 28.11.2021

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. Address: 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

64.01 EUR

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures 6XC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -137 964 881 EUR
Operating Margin TTM
PE Ratio
Return On Assets TTM -48.05 %
PEG Ratio
Return On Equity TTM -91.11 %
Wall Street Target Price 64.01 EUR
Revenue TTM
Book Value 6.52 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.61 EUR
Diluted Eps TTM -2.61 EUR
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 6XC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 6XC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 26.08.2022
Dividend Date

Stock Valuation 6XC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.0218
Price Book MRQ 8.9412

Financials 6XC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 6XC

For 52 weeks

20.42 EUR 53.27 EUR
50 Day MA 46.92 EUR
Shares Short Prior Month
200 Day MA 41.84 EUR
Short Ratio
Shares Short
Short Percent